563 related articles for article (PubMed ID: 24188445)
1. Cyclodextrin inclusion complex of racecadotril: effect of drug-β- cyclodextrin ratio and the method of complexation.
Semalty M; Panchpuri M; Singh D; Semalty A
Curr Drug Discov Technol; 2014 Jun; 11(2):154-61. PubMed ID: 24188445
[TBL] [Abstract][Full Text] [Related]
2. Preparation & characterization of solid inclusion complex of cefpodoxime proxetil with beta-cyclodextrin.
Bhargava S; Agrawal GP
Curr Drug Deliv; 2008 Jan; 5(1):1-6. PubMed ID: 18220545
[TBL] [Abstract][Full Text] [Related]
3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
4. Docetaxel/dimethyl-β-cyclodextrin inclusion complexes: preparation,
Giri BR; Lee J; Lim DY; Kim DW
Drug Dev Ind Pharm; 2021 Feb; 47(2):319-328. PubMed ID: 33576707
[TBL] [Abstract][Full Text] [Related]
5. Improved Aqueous Solubility and Antihypercholesterolemic Activity of Ezetimibe on Formulating with Hydroxypropyl-β-Cyclodextrin and Hydrophilic Auxiliary Substances.
Srivalli KM; Mishra B
AAPS PharmSciTech; 2016 Apr; 17(2):272-83. PubMed ID: 26077622
[TBL] [Abstract][Full Text] [Related]
6. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
Sinha VR; Nanda A; Chadha R; Goel H
Acta Pol Pharm; 2011; 68(4):585-92. PubMed ID: 21796941
[TBL] [Abstract][Full Text] [Related]
7. Inclusion Complexes of Hydroxy Propyl-β-Cyclodextrin and Paliperidone: Preparation and Characterization.
Sherje A; Londhe V
Curr Drug Discov Technol; 2014; 11(4):271-8. PubMed ID: 25578059
[TBL] [Abstract][Full Text] [Related]
8. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
Ozdemir N; Ordu S
Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
[TBL] [Abstract][Full Text] [Related]
9. Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement.
Semcheddine F; Guissi Nel I; Liu X; Wu Z; Wang B
AAPS PharmSciTech; 2015 Jun; 16(3):704-15. PubMed ID: 25511809
[TBL] [Abstract][Full Text] [Related]
10. Preparation and comparison of binary and ternary inclusion complexes of aripiprazole using L-arginine/lysine and MβCD/HPβCD by using different molar ratios.
Awais S; Afridi M; Batool A; Ansari MT; Sultana K; Momal H; Alsanie WF; S Alamri A; Alhomrani M
Pak J Pharm Sci; 2024 Jan; 37(1(Special)):245-255. PubMed ID: 38747276
[TBL] [Abstract][Full Text] [Related]
11. Effect of hydrophilic polymers on the solubility and dissolution enhancement of rivaroxaban/beta-cyclodextrin inclusion complexes.
Khan WH; Asghar S; Khan IU; Irfan M; Alshammari A; Riaz Rajoka MS; Munir R; Shah PA; Khalid I; Razzaq FA; Khalid SH
Heliyon; 2023 Sep; 9(9):e19658. PubMed ID: 37809727
[TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
13. Physico-chemical characterization and in vitro dissolution assessment of clonazepam-cyclodextrins inclusion compounds.
Patel R; Purohit N
AAPS PharmSciTech; 2009; 10(4):1301-12. PubMed ID: 19885735
[TBL] [Abstract][Full Text] [Related]
14. In-vitro dissolution and microbial inhibition studies on anticancer drug etoposide with β-cyclodextrin.
Arumugam SP; Balakrishnan SB; Ganesan V; Munisamy M; Kuppu SV; Narayanan V; Baskaralingam V; Jeyachandran S; Thambusamy S
Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():96-105. PubMed ID: 31147064
[TBL] [Abstract][Full Text] [Related]
15. Ternary Inclusion Complexes of Rifaximin with β-Cyclodextrin and Sodium Deoxycholate for Solubility Enhancement.
Kaur P; Rampal A; Singh Bedi PM; Bedi N
Curr Drug Discov Technol; 2015; 12(3):179-89. PubMed ID: 26279215
[TBL] [Abstract][Full Text] [Related]
16. Preparation of olanzapine and methyl-β-cyclodextrin complexes using a single-step, organic solvent-free supercritical fluid process: An approach to enhance the solubility and dissolution properties.
Rudrangi SR; Trivedi V; Mitchell JC; Wicks SR; Alexander BD
Int J Pharm; 2015 Oct; 494(1):408-16. PubMed ID: 26315120
[TBL] [Abstract][Full Text] [Related]
17. Inclusion complexes of hydrochlorothiazide and β-cyclodextrin: Physicochemical characteristics, in vitro and in vivo studies.
Mendes C; Buttchevitz A; Kruger JH; Kratz JM; Simões CM; de Oliveira Benedet P; Oliveira PR; Silva MA
Eur J Pharm Sci; 2016 Feb; 83():71-8. PubMed ID: 26687444
[TBL] [Abstract][Full Text] [Related]
18. Solid-state characterization and in vitro dissolution behavior of lorazepam: Hydroxypropyl-β-cyclodextrin inclusion complex.
Patel R; Patel M
Drug Discov Ther; 2010 Dec; 4(6):442-52. PubMed ID: 22491310
[TBL] [Abstract][Full Text] [Related]
19. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
[TBL] [Abstract][Full Text] [Related]
20. Water-soluble Complex of Curcumin with Cyclodextrins: Enhanced Physical Properties For Ocular Drug Delivery.
Maria DN; Mishra SR; Wang L; Abd-Elgawad AH; Soliman OA; El-Dahan MS; Jablonski MM
Curr Drug Deliv; 2017 Sep; 14(6):875-886. PubMed ID: 27501714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
